Immune Checkpoint Inhibitors Improves the Response to Salvage Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Response to Salvage Chemotherapy After Progression on Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Eur. J. Cancer 2019 Nov 01;121(xx)123-129, K Saleh, A Daste, N Martin, E Pons-Tostivint, A Auperin, RG Herrera-Gomez, N Baste-Rotllan, F Bidault, J Guigay, C Le Tourneau, E Saada-Bouzid, C EvenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.